The neuropsychological impacts of supratotal glioma resection: A systematic review
- 20 October 2026
- journal article
- review article
- Published by Oxford University Press (OUP) in Neuro-Oncology Practice
Abstract
Background: Supratotal resection (SpTR) has emerged as a compelling surgical target for gliomas, with a strong signal toward improved survival. However, the balance between resections extending into tumor-infiltrated normal brain and preservation of higher-order cognitive function remains poorly defined. This systematic review aims to characterize formal neuropsychological (NP) outcomes following glioma SpTR. Methods: A PRISMA-adherent systematic search was conducted across six electronic databases. Inclusion criteria required patients with WHO Grade 2-4 gliomas undergoing SpTR with standardized NP assessment. Quality was assessed using the Joanna Briggs Institute (JBI) Critical Appraisal Checklists. Results: Fifty-five studies reported SpTR for glioma, but only 11 (20%) utilized formal NP testing as an outcome. 80% of studies omitting NP testing focused exclusively on high-grade glioma (HGG). Cognitive data was available from 2 studies in HGG and 9 studies in LGG. Early post-operative cognitive declines were reported in 55.5% of extractable cohorts, predominantly in the domains of executive function and memory/learning. The majority of these studies report cognitive recovery after 3-6 months. Long-term permanent cognitive morbidity was indeed very low (∼1%), but critical appraisal revealed a high risk of bias. Conclusions: While current evidence suggests SpTR is functionally safe, these findings are limited by high risk of bias and a lack of comparative controls. A reporting gap remains in functional-cognitive outcomes after HGG surgery. Standardized, anatomically anchored NP testing will be essential to validate the “onco-functional balance” of supratotal margins.Keywords
This publication has 86 references indexed in Scilit:
- Defining the symptoms of personality and behaviour changes in brain tumour patients and their impact on caregiversSupportive Care in Cancer, 2025
- Pushing the boundaries of neurosurgical oncology: evaluating the superiority of supratotal resection over gross total resection in intraoperative MRI-guided glioma surgeryNeurosurgical Review, 2025
- Supramaximal resection: retrospective study on IDH-wildtype Glioblastomas based on the new RANO-Resect classificationActa Neurochirurgica, 2024
- Glioblastoma and Other Primary Brain Malignancies in AdultsJAMA, 2023
- Cognitive impairments are independently associated with shorter survival in diffuse glioma patientsJournal of Neurology, 2020
- Assessment of Karnofsky (KPS) and WHO (WHO-PS) performance scores in brain tumour patients: the role of clinician biasSupportive Care in Cancer, 2020
- Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experienceJournal of Neuro-Oncology, 2017
- Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a systematic review of neurocognitive functioning prior to anti-tumor treatmentJournal of Neuro-Oncology, 2017
- Association of the Extent of Resection With Survival in GlioblastomaJAMA Oncology, 2016
- Long-term outcomes after supratotal resection of diffuse low-grade gliomas: a consecutive series with 11-year follow-upActa Neurochirurgica, 2015